| 1 |
Su W, Qiu W, Li SJ, Wang S, Xie J, Yang QC, Xu J, Zhang J, Xu Z, Sun ZJ. A Dual-Responsive STAT3 Inhibitor Nanoprodrug Combined with Oncolytic Virus Elicits Synergistic Antitumor Immune Responses by Igniting Pyroptosis. Adv Mater 2023;35:e2209379. [PMID: 36545949 DOI: 10.1002/adma.202209379] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 2 |
Wan SC, Ye MJ, Yang QC, Zhang T, Zhang MJ, Ma XB, Xu JM, Wang S, Wu ZZ, Yang LL, Shen XM, Xu Z, Sun ZJ. Diselenide-Based Dual-Responsive Prodrug as Pyroptosis Inducer Potentiates Cancer Immunotherapy. Adv Healthc Mater 2023;12:e2202135. [PMID: 36479643 DOI: 10.1002/adhm.202202135] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 3 |
Ma X, Su W, Ye M, Gao Y, Qiu W, Liang M, Xue P, Kang Y, Sun Z, Xu Z. Endogenous/exogenous stimulies inspired polyprodrug nano-inducer switches pyroptosis path for promoting antitumor immunity. Nano Today 2023;48:101727. [DOI: 10.1016/j.nantod.2022.101727] [Reference Citation Analysis]
|
| 4 |
Zhang X, Hou S, Liang M, Xu J, Ye M, Wang Y, Wen F, Xu Z, Liu S. Engineering Nanofusiform Iron-doped Polydiaminopyridine Boost Intratumoral Penetration for Immunogenic Cell Death-mediated Synergistic Photothermal/Chemo Therapy. Chemical Engineering Journal 2023. [DOI: 10.1016/j.cej.2023.142159] [Reference Citation Analysis]
|
| 5 |
Zhang MJ, Liang MY, Yang SC, Ma XB, Wan SC, Yang QC, Wang S, Xu Z, Sun ZJ. Bioengineering of BRAF and COX2 inhibitor nanogels to boost the immunotherapy of melanoma via pyroptosis. Chem Commun (Camb) 2023;59:932-5. [PMID: 36597866 DOI: 10.1039/d2cc05498a] [Reference Citation Analysis]
|
| 6 |
Ferreira LAD, Rambo C, Gomes MJK, Ribeiro KDP, Nishimoto GA, Tisatto LGDR, Fritzen LD, da Cruz YB, Kambara AL, Rodrigues MJVB, Nogueira GA, Salvador HD, Oliveira-Toré CF, Reason IJM, Telles JEQ, Tomiotto-Pellissier F. Nanoparticles and phototherapy combination as therapeutic alternative in prostate cancer: A scoping review. Eur J Pharmacol 2023;939:175421. [PMID: 36435234 DOI: 10.1016/j.ejphar.2022.175421] [Reference Citation Analysis]
|
| 7 |
Chen J, Cong X. Surface-engineered nanoparticles in cancer immune response and immunotherapy: Current status and future prospects. Biomed Pharmacother 2023;157:113998. [PMID: 36399829 DOI: 10.1016/j.biopha.2022.113998] [Reference Citation Analysis]
|
| 8 |
Salehi S, Naghib SM, Garshasbi HR, Ghorbanzadeh S, Zhang W. Smart stimuli-responsive injectable gels and hydrogels for drug delivery and tissue engineering applications: A review. Front Bioeng Biotechnol 2023;11:1104126. [PMID: 36911200 DOI: 10.3389/fbioe.2023.1104126] [Reference Citation Analysis]
|
| 9 |
Ojha A, Jaiswal S, Bharti P, Mishra SK. Nanoparticles and Nanomaterials-Based Recent Approaches in Upgraded Targeting and Management of Cancer: A Review. Cancers (Basel) 2022;15. [PMID: 36612158 DOI: 10.3390/cancers15010162] [Reference Citation Analysis]
|
| 10 |
Jin X, Ji J, Sun Y. Preparation and characterization of morphine gelatine microspheres. Des Monomers Polym 2023;26:1-14. [PMID: 36567726 DOI: 10.1080/15685551.2022.2158571] [Reference Citation Analysis]
|
| 11 |
Hu W, Sun H, Pan L, Zhang C, Shen X, Su F, Song J. Poly(trimethylene carbonate)‐b‐poly(ethylene glycol) diblock copolymer micelles for hydrophobic drug delivery: The effect of hydrophilic/hydrophobic segment length on micellar properties and drug loading. Polymers for Advanced Techs 2022. [DOI: 10.1002/pat.5963] [Reference Citation Analysis]
|
| 12 |
Wei D, Mao Y, Wang H, Qu S, Chen J, Li J, Jiang B, Chen H. A mild phenoxysilyl linker for self-immolative release of antibody-drug conjugates. Chinese Chemical Letters 2022. [DOI: 10.1016/j.cclet.2022.108091] [Reference Citation Analysis]
|
| 13 |
Kumar N, Ghosh B, Kumar A, Koley R, Dhara S, Chattopadhyay S. Multilayered “SMART” hydrogel systems for on-site drug delivery applications. Journal of Drug Delivery Science and Technology 2022. [DOI: 10.1016/j.jddst.2022.104111] [Reference Citation Analysis]
|
| 14 |
Yu H, Wu M, Chen S, Song M, Yue Y. Biomimetic nanoparticles for tumor immunotherapy. Front Bioeng Biotechnol 2022;10. [DOI: 10.3389/fbioe.2022.989881] [Reference Citation Analysis]
|
| 15 |
Liao W, Li Y, Wang J, Zhao M, Chen N, Zheng Q, Wan L, Mou Y, Tang J, Wang Z. Natural Products-Based Nanoformulations: A New Approach Targeting CSCs to Cancer Therapy. Int J Nanomedicine 2022;17:4163-93. [PMID: 36134202 DOI: 10.2147/IJN.S380697] [Reference Citation Analysis]
|
| 16 |
Lv R, Li X, Song S, Wang H, Gao S, Zhang S, An Y, Zhou H, Ji Y, Xu Z. Fabrication and characterization of dual-responsive nanocarriers for effective drug delivery and synergistic chem-photothermal effects. Colloids and Surfaces A: Physicochemical and Engineering Aspects 2022. [DOI: 10.1016/j.colsurfa.2022.130256] [Reference Citation Analysis]
|
| 17 |
Huang Y, Lai H, Jiang J, Xu X, Zeng Z, Ren L, Liu Q, Chen M, Zhang T, Ding X, Zhao C, Cui S. pH-activatable oxidative stress amplifying dissolving microneedles for combined chemo-photodynamic therapy of Melanoma. Asian Journal of Pharmaceutical Sciences 2022. [DOI: 10.1016/j.ajps.2022.08.003] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
|
| 18 |
Hou M, Ye M, Liu L, Xu M, Liu H, Zhang H, Li Y, Xu Z, Li B. Azide-Locked Prodrug Co-Assembly into Nanoparticles with Indocyanine Green for Chemophotothermal Therapy. Mol Pharmaceutics. [DOI: 10.1021/acs.molpharmaceut.2c00452] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
|
| 19 |
Liang M, Zhang M, Qiu W, Xiao Y, Ye M, Xue P, Kang Y, Sun Z, Xu Z. Stepwise Size Shrinkage Cascade‐Activated Supramolecular Prodrug Boosts Antitumor Immunity by Eliciting Pyroptosis. Advanced Science. [DOI: 10.1002/advs.202203353] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 20 |
Zhang T, Guo S, Li F, Lan X, Jia Y, Zhang J, Huang Y, Liang XJ. Image-guided/improved diseases management: From immune-strategies and beyond. Adv Drug Deliv Rev 2022;188:114446. [PMID: 35820600 DOI: 10.1016/j.addr.2022.114446] [Reference Citation Analysis]
|
